Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for an Evrysdi® ...
Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...
15h
Positive Recommendation by DSMB to Continue Enrollment of Phase 3 SHIELD II Trial of D-PLEX₁₀₀ to 800 PatientsSHIELD II Enrolled more than ...
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries ; Evrysdi tablet can be stored at room temperature and offers the same demon ...
The edition this year promises to redefine the standards of aerospace expositions and elevate India’s global presence in the ...
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and sa ...
The Government of Karnataka launched its new industrial policy for 2025-30 at the inaugural session of Invest Karnataka 2025, the global investor meet being held in Bengaluru. The new policy aims to ...
Malay Mail on MSN1h
Education Ministry: 8,076 candidates were no-shows for 2024 SPM examsA total of 8,076 Sijil Pelajaran Malaysia (SPM) candidates did not sit for any written examination papers, according to data ...
Imagine having a company in your portfolio that has zero debt, and a high return on capital employed (ROCE), meaning they're ...
Investor Summit has drawn US$115 billion in investments, alongside the launch of its Industrial Policy 2025-30.
Backlash over ‘performative cruelty’ as small boat refugees blocked from gaining citizenship - Criticism comes days after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback